The difficulties of supply new technologies into the healthcare market: The case of tissue engineering

Thomas Johnsen (), W. Phillips, N Caldwell and J Chaudhuri
Additional contact information
Thomas Johnsen: Audencia Recherche - Audencia Business School

Post-Print from HAL

Abstract: This study provides an insight into the difficulties companies encounter in transposing basic science into commercially viable healthcare technologies, focusing on the issue of establishing a dominant supply model within a highly regulated market. The core issue is how to scale-up customised scientific processes into products able to supply wider and possibly mass markets. In tracing the development of approaches to scaling-up, the paper highlights the influence regulatory regimes have on high technology regulated products and services. The paper details the implications of two contrasting supply initiatives towards operationalising tissue engineering, based on differences in regulatory regimes between Europe and the USA.

Keywords: New technologies; Regulation; Supply (search for similar items in EconPapers)
Date: 2011-03
References: Add references at CitEc
Citations:

Published in Technology Analysis & Strategic Management, 2011, 23 (3), pp.213-226. ⟨10.1080/09537325.2011.550391⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-00771836

DOI: 10.1080/09537325.2011.550391

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().